Browse by author
Lookup NU author(s): Professor Allyson PollockORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2016, South African Medical Association. All rights reserved.The fast-track registration policy of the South African National Department of Health allows for rapid registration of new medicines of public health importance and of all medicines on the Essential Medicines List, most of which are generics. No limit is placed on the number of generic brands of a medicine that can be submitted for fast-track registration. This, together with resource constraints at the regulator, may delay access to important new medicines, new fixed-dose combinations of critical medicines or affordable versions of biological medicines (biosimilars). One reason for not limiting the number of fast-track generic applications was to promote price competition among generic brands. We found this not to be valid, since market share correlated poorly with price. Generic brands with high market share were, mostly, those that were registered first. We propose that the number of generic brands accepted for fast-tracking be limited to not more than seven per medicine.
Author(s): Leng HMJ, Pollock AM, Sanders D
Publication type: Article
Publication status: Published
Journal: South African Medical Journal
Year: 2016
Volume: 106
Issue: 4
Pages: 350-353
Print publication date: 01/04/2016
Online publication date: 17/03/2016
Acceptance date: 09/11/2015
ISSN (print): 0256-9574
ISSN (electronic): 2078-5135
Publisher: South African Medical Association
URL: https://doi.org/10.7196/SAMJ.2016.v106i4.10237
DOI: 10.7196/SAMJ.2016.v106i4.10237
PubMed id: 27032846
Altmetrics provided by Altmetric
